Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe
Tickers HALO RHHBY
Tags why it's moving General RHHBY
From Benzinga
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
Tickers MRK NEWS RHHBY
Tags FDA General Briefs
From Benzinga
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
Tickers AMGN AMZN COR GOOGL
Tags Market News NVDA MDT
From Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
Tickers DXCM RHHBY SRPT
Tags RHHBY SRPT DXCM
From Motley Fool
Why Is LumiraDx (LMDX) Stock Down 13% Today?
Tickers CLRB HARP LMDX RHHBY
Tags Today's Market NASDAQ:LMDX,OTCMKTS:RHHBY,NASDAQ:CLRB,NASDAQ:HARP LMDX
From InvestorPlace
3 Great Foreign Companies to Invest in Right Now
Tickers ASML RHHBY TEAM
Tags Market News Recent Press Releases ASML
From Motley Fool
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
Tickers LMDX NEWS RHHBF RHHBY
Tags News Health Care Trading Ideas
From Benzinga
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
Tickers AZN LLY NVO PFE
Tags Recent Press Releases NVO LLY
From Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
Tickers CALT MCK NVS RHHBY
Tags RHHBY NVS Market News
From Benzinga
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
Tickers NVDA RHHBY
Tags Market News Recent Press Releases NVDA
From Motley Fool
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
Tickers IPO IPOS NVO RHHBY
Tags News NVO Health Care
From Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in December
Tickers INCY KNSA NBIX RHHBY
Tags RHHBY NBIX NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:NBIX,NASDAQ:INCY
From InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
Tickers PSTX RHHBF RHHBY RHHVF
Tags RHHBY why it's moving Market News
From Benzinga
Why Viking Therapeutics Was Crushing It This Week
Tickers NVO RHHBY VKTX
Tags NVO Market News Recent Press Releases
From Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
Tickers ALT AZN LLY NVO
Tags ALT AZN RHHBY
From MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
Tickers ALT JNJ LLY NVO
Tags Briefs PFE Benzinga
From Benzinga
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
Tickers ALT MYNZ PFE RHHBY
Tags Penny Stocks contributors Markets
From Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
Tickers RHHBF RHHBY RHHVF
Tags Briefs Benzinga Biotech
From Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Tickers LLY NVO RHHBY
Tags Market News RHHBY Jim Cramer
From Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
Tickers LLY NVO RHHBF RHHBY
Tags RHHBY Market News M&A
From Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
Tickers ABSI AZN NVDA RHHBY
Tags Penny Stocks Health Care News
From Benzinga
Ignore Crypto: These Stocks Could Make You Rich
Tickers MDT NEE RHHBY
Tags NEE RHHBY MDT
From Motley Fool
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
Tickers CLDX LUNG PSTX RHHBY
Tags RHHBY PSTX Stocks to Buy
From InvestorPlace
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
Tickers AZN BMY MRK RHHBY
Tags News Large Cap Equities
From Benzinga
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
Tickers BIIB LLY RHHBY
Tags Recent Press Releases Market News LLY
From Motley Fool
Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug
Tickers REGN RHHBY
Tags Market News why it's moving RHHBY
From Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
Tickers RHHBF RHHBY RHHVF SRPT
Tags Benzinga Biotech Movers
From Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
Tickers BHC CAH CVS NVS
Tags Eye care News CVS
From Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Tickers LLY PFE RHHBY
Tags Recent Press Releases Market News LLY
From Motley Fool
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
Tickers PFE RHHBY ROIV XBI
Tags Market News Recent Press Releases RHHBY
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.